Linezolid is superior to vancomycin in experimental pneumonia caused by superantigen-producing Staphylococcus aureus in HLA class II transgenic mice

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 10, 2012, Pages 5401-5405

  Karau, Melissa J ^a   Tilahun, Ashenafi Y ^b   Schmidt, Suzannah M ^a   Clark, Chad R ^b   Patel, Robin ^a   Rajagopalan, Govindarajan ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 6; LINEZOLID; SUPERANTIGEN; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL PROLIFERATION; DRUG EFFICACY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANIMALS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OXAZOLIDINONES; PNEUMONIA, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VANCOMYCIN;

EID: 84866335431     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01080-12     Document Type: Article

References (20)

1. Akinnusi ME, Hattemer A, Gao W, El-Solh AA. 2011. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia? Crit. Care Med. 39:1944-1952.
2. Annane D, Clair B, Salomon J. 2004. Managing toxic shock syndrome with antibiotics. Expert Opin. Pharmacother. 5:1701-1710. (Pubitemid 39117713)
3. Cruciani M, et al. 1996. Penetration of vancomycin into human lung tissue. J. Antimicrob. Chemother. 38:865-869. (Pubitemid 26413723)
4. Fey PD, et al. 2003. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:196-203. (Pubitemid 36070364)
5. Fraser J, Arcus V, Kong P, Baker E, Proft T. 2000. Superantigens - powerful modifiers of the immune system. Mol. Med. Today 6:125-132.
6. Kalil AC. 2011. Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results? Crit. Care Med. 39:2009-2010.
7. Lodise TP, et al. 2011. Penetration of vancomycin into epithelial lining fluid in healthy volunteers. Antimicrob. Agents Chemother. 55:5507-5511.
8. Mushtaq F, Hildrew S, Okugbeni G, Ellis RW. 2008. Necrotizing haemorrhagic pneumonia proves fatal in an immunocompetent child due to Panton-Valentine leucocidin, toxic shock syndrome toxins 1 and 2 and enterotoxin C-producing Staphylococcus aureus. Acta Paediatr. 97:985-987. (Pubitemid 351792815)
9. Proft T, Fraser JD. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133:299-306. (Pubitemid 37051503)
10. Schlievert PM. 2009. Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 200:676-678.
11. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. 2010. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J. Allergy Clin. Immunol. 125:39-49.
12. Shukla SK, et al. 2010. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J. Clin. Microbiol. 48:3582-3592.
13. Sriskandan S, et al. 2001. Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J. Infect. Dis. 184:166-173. (Pubitemid 32614045)
14. Stevens DL, et al. 2007. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 195:202-211. (Pubitemid 46080052)
15. Thomas D, et al. 2009. Staphylococcus aureus superantigens elicit redundant and extensive human Vβ patterns. Infect. Immun. 77:2043-2050.
16. Tilahun AY, Karau MJ, Clark CR, Patel R, Rajagopalan G. 2012. The impact of tacrolimus on the immunopathogenesis of staphylococcal enterotoxin-induced systemic inflammatory response syndrome and pneumonia. Microbes Infect. 14:528-536.
17. Tilahun AY, et al. 2011. Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. Am. J. Pathol. 178:2760-2773.
18. Vojtov N, Ross HF, Novick RP. 2002. Global repression of exotoxin synthesis by staphylococcal superantigens. Proc. Natl. Acad. Sci. U. S. A. 99:10102-10107. (Pubitemid 34831179)
19. Wilson GJ, et al. 2011. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 7:e1002271. doi:10.1371/journal.ppat.1002271.
20. Yanagihara K, et al. 2002. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob. Agents Chemother. 46: 3288-3291.